| |
| |
|
| Insider
Information: |
Asadorian Raffi |
| Relationship: |
Chief Financial Officer |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
279,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,971 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
279,381 |
|
|
| Total
Value |
$38,971 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amyris, Inc. |
AMRS |
Chief Financial Officer |
2017-01-01 |
241,648 |
2015-01-20 |
0 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
Chief Financial Officer |
2024-03-03 |
37,733 |
2017-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2024-03-03 |
4 |
D |
$1.30 |
$725 |
D/D |
(558) |
37,733 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
38,291 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2024-02-11 |
4 |
D |
$1.10 |
$985 |
D/D |
(895) |
20,291 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2024-02-10 |
4 |
D |
$1.10 |
$985 |
D/D |
(895) |
21,186 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-03-03 |
4 |
D |
$1.31 |
$668 |
D/D |
(510) |
22,081 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-02-11 |
4 |
D |
$1.68 |
$1,467 |
D/D |
(873) |
22,591 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,875 |
23,464 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-02-06 |
4 |
D |
$2.02 |
$1,246 |
D/D |
(617) |
17,589 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-03-03 |
4 |
D |
$0.41 |
$3,223 |
D/D |
(7,923) |
364,205 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-02-11 |
4 |
D |
$0.40 |
$3,182 |
D/D |
(7,927) |
368,080 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
117,500 |
376,015 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-02-06 |
4 |
D |
$0.43 |
$4,049 |
D/D |
(9,391) |
258,515 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
68,750 |
260,597 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2021-02-11 |
4 |
D |
$2.63 |
$23,733 |
D/D |
(9,024) |
183,299 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2021-02-06 |
4 |
D |
$2.59 |
$24,382 |
D/D |
(9,414) |
192,323 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2020-02-11 |
4 |
D |
$1.71 |
$13,550 |
D/D |
(7,924) |
188,765 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
68,750 |
196,689 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2019-02-28 |
4 |
B |
$2.81 |
$10,248 |
D/D |
3,647 |
124,397 |
2.74 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
68,750 |
120,750 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-12-14 |
4 |
B |
$2.78 |
$13,883 |
D/D |
5,000 |
52,000 |
2.74 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-11-13 |
4 |
B |
$3.13 |
$15,646 |
D/D |
5,000 |
47,000 |
2.74 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-08-31 |
4 |
A |
$1.49 |
$14,900 |
D/D |
10,000 |
42,000 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-08-06 |
4 |
B |
$2.75 |
$13,725 |
D/D |
5,000 |
32,000 |
2.74 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-05-25 |
4 |
B |
$3.18 |
$15,923 |
D/D |
5,000 |
27,000 |
2.74 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2017-11-13 |
4 |
B |
$1.94 |
$9,711 |
D/D |
5,000 |
12,000 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
